US FDA approves "grandfathered" oxycodone products

The US FDA has approved new drug applications (NDAs) for a line of controlled substance products containing oxycodone hydrochloride, said partners Lehigh Valley Technologies (LVT) and Glenmark Generics Inc, a US subsidiary of the Indian firm Glenmark.

The US FDA has approved new drug applications (NDAs) for a line of controlled substance products containing oxycodone hydrochloride, said partners Lehigh Valley Technologies (LVT) and Glenmark Generics Inc, a US subsidiary of the Indian firm Glenmark.

The approval gives LVT and Glenmark manufacturing and distribution rights to the only FDA-approved oxycodone immediate release capsules and oral...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip